Grzegorz Zycinski

Learn More
In computational biology, the analysis of high-throughput data poses several issues on the reliability, reproducibility and interpretabil-ity of the results. It has been suggested that one reason for these inconsistencies may be that in complex diseases, such as cancer, multiple genes belonging to one or more physiological pathways are associated with the(More)
High–throughput (HT) technologies provide huge amount of gene expression data that can be used to identify biomarkers useful in the clinical practice. The most frequently used approaches first select a set of genes (i.e. gene signature) able to characterize differences between two or more phenotypical conditions, and then provide a functional assessment of(More)
  • 1